Skip to contentA
Aeternum Health, Inc.
A
AETNAeternum Health, Inc. Q2 2020 · 10-Q
Revenue$0.00$0.00— vs Q2 2019 Net Income-$10.91K-$10.91KN/M vs Q2 2019 EPS Diluted-$0.01-$0.01N/M vs Q2 2019 Operating Income-$10,912N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aeternum Health, Inc. · CIK 764630 · Engraved from SEC EDGAR
derived
ended Aug 31, 2019 · filed Dec 20, 2019 · 111 d after period end